MedPath
NMPA Approval

Moxifloxacin Hydrochloride and Sodium Chloride Injection

国药准字H20249077

October 16, 2024

Drug Information

盐酸莫西沙星氯化钠注射液

注射剂

250ml:盐酸莫西沙星(按C₂₁H₂₄FN₃O₄计)0.4g与氯化钠2.0g

化学药品

October 16, 2024

Company Information

Applicant Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区华云路1号东坊产业园C区8号楼5楼

Manufacturing Company

临沂市罗庄区罗七路中段西侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星氯化钠注射液 - NMPA 批准文号 | MedPath